Monarch Medical Technologies Named Among TIME’s World’s Top HealthTech Companies 2025

Innovation in patient-specific insulin dosing just earned global recognition as Monarch Medical Technologies has been recognized by TIME and Statista on their list of the World’s Top HealthTech Companies 2025.

This recognition underscores the impact of our mission: creating a world where every inpatient insulin dose is the right one.

Monarch is the only company in the U.S. solely dedicated to patient-specific insulin dosing software, trusted by 8 of the nation’s top 10 health systems. Each day, EndoTool delivers thousands of patient-specific dosing recommendations – helping hospitals improve outcomes, reduce risk, and relieve the burden on frontline clinicians.

“Being included alongside innovators from around the globe highlights the growing importance of precision in healthcare technology,” said Charles Cornish, Chief Executive Officer, Monarch Medical Technologies.

“For us, it’s also validation of the years of collaboration with clinicians, nurses, and health system leaders who continue to advance patient-specific glycemic care,” he said.

As healthcare enters a new era of connected care, we’re honored to be recognized as a leader helping set the standard for inpatient glucose management.

 Read the full TIME list here.